ELASMOGEN

elasmogen-logo

Elasmogen is developing soloMERs: fully humanized, next generation, single chain therapeutics for auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical candidates derived from VNARS (variable new-antigen receptors) which exist naturally in sharks as high affinity binding domains. With a different ancestral origin from antibodies this example of 400 million year old convergent evolution places VNARs outside of the complex paten... t landscape that describes and protects antibody drug discovery and has produced the smallest (9% of the size of an antibody) and most robust naturally occurring binding domain. Elasmogen is unique in its capacity to isolate and develop soloMERs, with a multi-layered IP position covering the platform, products and process including an exclusive license to over 20 patents granted in the US, Europe and other territories together with the entire know-how and VNAR pipeline/product output from the Scottish Biologics Facility, University of Aberdeen.

#SimilarOrganizations #People #Financial #Event #Website #More

ELASMOGEN

Social Links:

Industry:
Medical Therapeutics

Founded:
2014-01-01

Address:
Aberdeen, Aberdeen City, United Kingdom

Country:
United Kingdom

Website Url:
http://www.elasmogen.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
16.95 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Nginx


Similar Organizations

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

neos-therapeutics-logo

Neos Therapeutics

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

paindrainer-logo

PainDrainer

PainDrainer AB is a Swedish company.

perlara-logo

Perlara

Perlara, PBC is precision drug discovery that leaves no mutation behind.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

vetsource-logo

Vetsource

Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.


Current Advisors List

not_available_image

Jane Dancer Board of Directors @ Elasmogen
Board_member

Current Employees Featured

caroline-barelle_image

Caroline Barelle
Caroline Barelle Chief Executive Officer and founder @ Elasmogen
Chief Executive Officer and founder
2015-05-01

chris-jones_image

Chris Jones
Chris Jones Executive Chairman @ Elasmogen
Executive Chairman
2016-04-01

Founder


caroline-barelle_image

Caroline Barelle

Investors List

business-growth-fund_image

Business Growth Fund

Business Growth Fund investment in Venture Round - Elasmogen

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Venture Round - Elasmogen

scottish-national-investment-bank_image

Scottish National Investment Bank

Scottish National Investment Bank investment in Venture Round - Elasmogen

scottish-government_image

Scottish Government

Scottish Government investment in Grant - Elasmogen

deepbridge-capital_image

Deepbridge Capital

Deepbridge Capital investment in Venture Round - Elasmogen

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Elasmogen

scottish-investment-bank_image

Scottish Investment Bank

Scottish Investment Bank investment in Grant - Elasmogen

deepbridge-capital_image

Deepbridge Capital

Deepbridge Capital investment in Seed Round - Elasmogen

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Grant - Elasmogen

biotechnology-and-biological-sciences-research-council-bbsrc_image

Biotechnology and Biological Sciences Research Council

Biotechnology and Biological Sciences Research Council investment in Grant - Elasmogen

Newest Events participated

pitchpalace-50_event_image Participated in Pitch@Palace 5.0 on 2016-03-07 as exhibitor

Official Site Inspections

http://www.elasmogen.com Semrush global rank: 6.98 M Semrush visits lastest month: 656

  • Host name: scarif-lon1.krystal.uk
  • IP address: 77.72.1.44
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Elasmogen"

Elasmogen - Crunchbase Company Profile & Funding

Elasmogen is unique in its capacity to isolate and develop soloMERs, with a multi-layered IP position covering the platform, products and process including โ€ฆSee details»

Elasmogen Ltd Information - RocketReach

Elasmogen is a therapeutic biologics company developing multi-functional products for difficult-to-treat diseases. The company has built a product pipeline that exploits the advantages of its โ€ฆSee details»

Elasmogen 2025 Company Profile: Valuation, Funding & Investors

Elasmogen General Information Description. Developer of novel therapies designed to treat inflammatory, autoimmune diseases and cancer. The company's therapies focus on auto โ€ฆSee details»

Elasmogen - Headquarter Location, Corporate Office Address and โ€ฆ

Elasmogen is Drug Discovery in United Kingdom that focus on inflammatory conditions business. Founded in 2014. They cover business area such as Provider, biopharmaceutical service, โ€ฆSee details»

Elasmogen - The Org

Elasmogen is a precision biologics drug discovery company that develops soloMERs. Industries. Health Care, TherapeuticsSee details»

Elasmogen Company Profile - Office Locations, Competitors ... - Craft

Elasmogen is a therapeutic biologics company that is focused on the development of drugs based on a protein found in a sharkโ€™s immune system. It exploits soloMER technology as drugs in โ€ฆSee details»

Elasmogen Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Elasmogen is unique in its capacity to isolate and develop soloMERs, with a multi-layered IP position covering the platform, humanisation, formats, products and process including over 25 โ€ฆSee details»

Elasmogen - Funding, Financials, Valuation & Investors - Crunchbase

Elasmogen is a precision biologics drug discovery company that develops soloMERs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. โ€ฆSee details»

Elasmogen - VentureRadar

Mar 22, 2019 Elasmogen Ltd is discovering and developing soloMERโ„ขs for the treatment of auto-immune mediated, inflammatory diseases. Utilising its unique soloMERโ„ข platform, โ€ฆSee details»

elasmogen.com - Elasmogen - discovering and de... - Elasmogen

ELASMOGEN โ€“ discovering and developing soloMERs for the treatment of auto-immune mediated. Elasmogen is progressing next generation biologics for inflammatory, autoimmune โ€ฆSee details»

ELASMOGEN LIMITED Company Profile - Dun & Bradstreet

Elasmogen limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / aberdeen / โ€ฆSee details»

Elasmogen Ltd - Company Profile

Elasmogen Ltd is a next generation therapeutic biologics company discovering and developing soloMERsโ„ข for the treatment of auto-immune mediated, inflammatory diseases. Utilising its โ€ฆSee details»

Elasmogen - Overview, News & Similar companies | ZoomInfo.com

May 18, 2022 Who is Elasmogen. Elasmogen is a privately-held biopharmaceutical company located in the thriving biologics cluster in Aberdeen, Scotland. The Company is rapidly pro โ€ฆSee details»

Elasmogen - Contacts, Employees, Board Members, Advisors

Organization. Elasmogen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Elasmogen has 2 current employee profiles, including โ€ฆSee details»

ELASMOGEN START-UP JOURNEY - Deepbridge Capital

GBI Magazine recently spoke to Dr Caroline Barelle, CEO & Founder of Elasmogen, to talk about her Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.. โ€ฆSee details»

Next-generation biologics: todayโ€™s reality - Bioscience Today

Shark molecules provide the basis of unique new therapeutics which could transform the treatment of inflammatory diseases and cancer. Karen Southern talks to Dr Caroline Barelle, โ€ฆSee details»

Elasmogen wins grants | ONE - ONE (en-GB)

Jul 9, 2020 In April 2020, Elasmogen secured £143,000 from the Scottish Government to use their drug discovery platform to accelerate the development of new diagnostics and โ€ฆSee details»

Elasmogen - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Mar 10, 2025 Elasmogen is a precision biologics drug discovery company that develops soloMERs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log โ€ฆSee details»

elasmogen | Deepbridge Capital

Elasmogen Secure £8M Funding Round Elasmogen , which is part of the Deepbridge Life Sciences EIS fund, recently secured £8 million in their latest funding round. This investment โ€ฆSee details»

linkstock.net © 2022. All rights reserved